MELINTA THERAPEUTICS, INC. /NEW/: key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2018)
- $96.4M
- Net Income/Loss (FY2018)
- -$157.2M
- Total Assets (FY2018)
- $441.6M
- Total Equity (FY2018)
- $190.1M
- Cash Flows from Operating Activities (FY2018)
- -$171.5M
Source: MELINTA THERAPEUTICS, INC. /NEW/ 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
